177 related articles for article (PubMed ID: 15216398)
21. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
Gao W; Romkes M; Zhong S; Nukui T; Persad RA; Smith PJ; Branch R; Keohavong P
Oncol Rep; 2010 Jul; 24(1):257-62. PubMed ID: 20514470
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study.
Saadat M; Kohan L; Omidvari S
Breast Cancer Res Treat; 2008 Oct; 111(3):549-53. PubMed ID: 17987379
[TBL] [Abstract][Full Text] [Related]
23. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
24. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
[TBL] [Abstract][Full Text] [Related]
25. The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells.
Oliveira S; Sousa H; Santos AM; Pinto D; Pinto-Correia AL; Fontoura D; Moutinho J; Medeiros R
J Med Virol; 2008 Mar; 80(3):424-9. PubMed ID: 18205229
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract][Full Text] [Related]
27. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.
Chiang CC; Tsai YY; Bau DT; Cheng YW; Tseng SH; Wang RF; Tsai FJ
Mol Vis; 2010 Apr; 16():698-704. PubMed ID: 20431719
[TBL] [Abstract][Full Text] [Related]
28. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.
Laprano TD; Lemos EH; Cunha LM; Júnior JE; de SousaTeles RA; Rabenhorst SH
Tumour Biol; 2014 Aug; 35(8):7435-40. PubMed ID: 24782034
[TBL] [Abstract][Full Text] [Related]
29. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population.
Radwan WM; Elbarbary HS; Alsheikh NM
Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768
[TBL] [Abstract][Full Text] [Related]
30. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Cheng XD; Lu WG; Ye F; Wan XY; Xie X
J Exp Clin Cancer Res; 2009 Jun; 28(1):91. PubMed ID: 19563645
[TBL] [Abstract][Full Text] [Related]
31. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
32. The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection.
Huang J; Ye F; Chen H; Lu W; Xie X
Int J Gynecol Cancer; 2007; 17(3):668-75. PubMed ID: 17504380
[TBL] [Abstract][Full Text] [Related]
33. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
34. HPV16 E6 mutations and p53 codon72 polymorphism among women with cervical intraepithelial neoplasia 2 and 3 in China.
Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
Eur J Gynaecol Oncol; 2016; 37(5):649-652. PubMed ID: 29787003
[TBL] [Abstract][Full Text] [Related]
35. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
Wang YD; Zhai WL; Wang HY; Xia XQ
Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
[TBL] [Abstract][Full Text] [Related]
36. XPD and XRCC1 gene polymorphism in patients with normal and abnormal cervical cytology by pap smear.
Yilmaz E; Celik O; Celik E; Turkcuoglu I; Simsek Y; Karaer A; Otlu B; Gulbay G; Yesilada E
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1713-8. PubMed ID: 23161045
[TBL] [Abstract][Full Text] [Related]
37. Association between polymorphisms of DNA repair gene XRCC1 and DNA damage in asbestos-exposed workers.
Zhao XH; Jia G; Liu YQ; Liu SW; Yan L; Jin Y; Liu N
Biomed Environ Sci; 2006 Jun; 19(3):232-8. PubMed ID: 16944782
[TBL] [Abstract][Full Text] [Related]
38. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.
Assoumou SZ; Boumba AL; Ndjoyi-Mbiguino A; Khattabi A; Ennaji MM
Med Oncol; 2015 Jan; 32(1):281. PubMed ID: 25502079
[TBL] [Abstract][Full Text] [Related]
39. Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily.
Agodi A; Barchitta M; Cipresso R; Marzagalli R; La Rosa N; Caruso M; Castiglione MG; Travali S
Int J Gynecol Cancer; 2010 Jan; 20(1):141-6. PubMed ID: 20130515
[TBL] [Abstract][Full Text] [Related]
40. Lifetime exposure to environmental tobacco smoke and cervical intraepithelial neoplasms among nonsmoking Taiwanese women.
Wu MT; Lee LH; Ho CK; Liu CL; Wu TN; Wu SC; Lin LY; Cheng BH; Yang CY
Arch Environ Health; 2003 Jun; 58(6):353-9. PubMed ID: 14992310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
